Clinical Trial Update: A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients. [Phase 2]

View source ↗

Summary

A Phase 2 trial in operable Head and Neck Squamous Cell Carcinoma compares low-dose radiotherapy plus targeted therapy and immunotherapy versus targeted therapy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Snippet

Sponsor: West China Hospital | Conditions: Head and Neck Squamous Cell Carcinoma, Low-dose Radiotherapy | Phase 2 | Status: RECRUITING